The Maharashtra Food and Drugs Administration (FDA) on Sunday (October 5, 2025), issued an urgent advisory calling for the immediate suspension of sale, distribution, and use of Coldrif Syrup, following reports of child fatalities in Madhya Pradesh and Rajasthan allegedly linked to the product.
The affected batch, Coldrif Syrup (Phenylephrine Hydrochloride, Chlorpheniramine Maleate), Batch No.
Continue Reading on The Hindu
This preview shows approximately 15% of the article. Read the full story on the publisher's website to support quality journalism.